 Westport, Connecticut--Newsfile Corp. - June 29, 2021 - Portage Biotech Inc., NASDAQ: PRTG Portage or the Company a clinical-stage immuno-oncology company focused on the development of therapies targeting cancer treatment resistance, today announced that the Company has been added to the Russell 2000 Index at the conclusion of the 2021 Russell Indexes annual reconstitution, effective after the U.S. market opened on June 28. Inclusion in the Russell 2000 index marks another key milestone for Portage,... 